Lung Ultrasound Score As Post Operative Predictive Value of Pulmonary Complications in Living Liver Transplant Recipient
Launched by AIN SHAMS UNIVERSITY · Jul 6, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how well a lung ultrasound score can predict the chance of breathing problems after a living liver transplant. The researchers want to see if this test can help doctors identify patients who may face complications in the days following their surgery, which is important for improving patient care and recovery.
To participate in this study, you need to be an adult aged 21 to 60 who has just had a living liver transplant and is currently in the intensive care unit during the first day after surgery. Both men and women can join, but you won’t be eligible if you have any ongoing lung diseases before the surgery. If you participate, you can expect to have a lung ultrasound done to help assess your risk for any potential breathing issues. This study is not yet recruiting participants, but it aims to gather important information that could benefit future liver transplant patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • living liver transplant recipient patients post operative in intensive care unit in first day
- • Age ( Adults 21-60 )
- • Sex ( both genders will be included )
- • ASA 4 liver failure patients .
- Exclusion Criteria:
- • Presence of preoperative chronic lung diseases
About Ain Shams University
Ain Shams University, established in Cairo, Egypt, is a prestigious higher education institution renowned for its commitment to academic excellence and research innovation. As a clinical trial sponsor, the university leverages its extensive resources and expertise in various medical and scientific disciplines to advance healthcare through rigorous research initiatives. With a focus on ethical practices and adherence to regulatory standards, Ain Shams University aims to contribute to the development of new therapies and improve patient outcomes, fostering collaboration among researchers, healthcare professionals, and industry partners in the pursuit of medical advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported